Journal of the American Pharmacists Association : JAPhA
-
J Am Pharm Assoc (2003) · Jan 2013
ReviewClass-wide REMS for extended-release and long-acting opioids: potential impact on pharmacies.
To provide an update on the recently approved class-wide risk evaluation and mitigation strategy (REMS) for extended-release (ER) and long-acting (LA) opioids and to discuss the potential impact on pharmacy practice. ⋯ Although the changing requirements for prescribing ER/LA opioids will not have a direct effect on pharmacist workflow, the pharmacist-patient interaction remains critical for overall risk reduction with this class of medication.
-
J Am Pharm Assoc (2003) · Jan 2013
Postdischarge pharmacist medication reconciliation: impact on readmission rates and financial savings.
To assess the impact of ambulatory clinical pharmacist medication therapy assessment and reconciliation for patients postdischarge in terms of hospital readmission rates, financial savings, and medication discrepancies. ⋯ Most literature on medication reconciliation evaluates inpatient processes, whereas data on medication reconciliation postdischarge are limited. Our data support the hypothesis that medication assessment and reconciliation by pharmacists 3 to 7 days postdischarge can decrease readmissions and provide cost savings.